Combination Gemcitabine, Carboplatin With or Without Trastuzumab in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: Carboplatin|DRUG: Trastuzumab
Sponsor: SCRI Development Innovations, LLC
Collaborators: Eli Lilly and Company|Genentech, Inc.